In the past years several new urinary nephrotoxicity biomarkers have been qualified for use in preclinical studies by the FDA and EMA
Comparison of the MesoScale Discovery and Luminex Multiplex Platforms for Measurement of Urinary Biomarkers in a Cisplatin Rat Kidney Injury Model
Journal of Pharmacological and Toxicological Methods, 2014